146 related articles for article (PubMed ID: 3053015)
1. Malignant hyperthermia.
Glisson SN
Compr Ther; 1988 Oct; 14(10):33-41. PubMed ID: 3053015
[No Abstract] [Full Text] [Related]
2. Malignant hyperthermia.
Sessler DI
Acta Anaesthesiol Scand Suppl; 1996; 109():25-30. PubMed ID: 8901933
[No Abstract] [Full Text] [Related]
3. In vitro contracture tests for susceptibility to malignant hyperthermia.
Rosenberg H; Reed S
Anesth Analg; 1983 Apr; 62(4):415-20. PubMed ID: 6829945
[No Abstract] [Full Text] [Related]
4. Malignant hyperthermia in the absence of triggering agents.
Setzer-Saade N
Anesth Analg; 2010 Sep; 111(3):822; author reply 822-3. PubMed ID: 20733170
[No Abstract] [Full Text] [Related]
5. [Drug-induced malignant hyperthermia].
Ichihara Y; Kikuchi H
Nihon Rinsho; 2007 Oct; 65 Suppl 8():326-30. PubMed ID: 18074557
[No Abstract] [Full Text] [Related]
6. [Malignant hyperthermia].
Glahn KP
Ugeskr Laeger; 2003 Apr; 165(17):1763-8. PubMed ID: 12768904
[TBL] [Abstract][Full Text] [Related]
7. [Malignant hyperthermia].
Campos Suárez JM; Escolano Villén F; Catalá Puigbó E; Villar Landeira JM
Rev Esp Anestesiol Reanim; 1985; 32(4):169-78. PubMed ID: 3901157
[No Abstract] [Full Text] [Related]
8. Masseter muscle spasm and the diagnosis of malignant hyperthermia susceptibility.
Ellis FR; Hopkins PM; Halsall PJ; Christian AS
Anesth Analg; 1992 Jul; 75(1):143-6. PubMed ID: 1616144
[No Abstract] [Full Text] [Related]
9. Malignant hyperthermia.
Willner J
Pediatr Ann; 1984 Feb; 13(2):128, 130, 132-4. PubMed ID: 6369232
[No Abstract] [Full Text] [Related]
10. [Malignant hyperthermia and new halogen agents].
Adnet P; Krivosic-Horber R
Ann Fr Anesth Reanim; 2000 Jun; 19(6):f 115-7. PubMed ID: 10941457
[No Abstract] [Full Text] [Related]
11. Be prepared: malignant hyperthermia.
DeJohn P
OR Manager; 2008 Jun; 24(6):26-7, 30. PubMed ID: 18655686
[No Abstract] [Full Text] [Related]
12. [Neurological aspects of malignant hyperthermia. Clinics, physiopathology, genetics].
Serratrice G; Kozak-Ribbens G; Cozzone PJ
Rev Neurol (Paris); 1997 Jun; 153(5):304-13. PubMed ID: 9296164
[TBL] [Abstract][Full Text] [Related]
13. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
Monnier N; Lunardi J
Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
[TBL] [Abstract][Full Text] [Related]
14. Malignant hyperthermia: advances in clinical management and diagnosis.
Hopkins PM
Br J Anaesth; 2000 Jul; 85(1):118-28. PubMed ID: 10928000
[No Abstract] [Full Text] [Related]
15. Malignant hyperthermia: review of the syndrome with report of a case.
Shaenboen MJ; Finkel PH
J Am Osteopath Assoc; 1986 Jun; 86(6):383-9. PubMed ID: 3733488
[No Abstract] [Full Text] [Related]
16. Masseter muscle rigidity and malignant hyperthermia susceptibility.
Rosenberg H; Fletcher JE
Anesth Analg; 1986 Feb; 65(2):161-4. PubMed ID: 3942303
[TBL] [Abstract][Full Text] [Related]
17. Masseter muscle spasm in children.
Rosenberg H; Shutack JG
Anesth Analg; 1991 Sep; 73(3):361-3. PubMed ID: 1843449
[No Abstract] [Full Text] [Related]
18. [Malignant hyperthermia].
Nalda MA; González-Machado JL
Med Clin (Barc); 1985 Jan; 84(2):74-7. PubMed ID: 2983154
[No Abstract] [Full Text] [Related]
19. Malignant hyperthermia during sevoflurane administration.
Ducart A; Adnet P; Renaud B; Riou B; Krivosic-Horber R
Anesth Analg; 1995 Mar; 80(3):609-11. PubMed ID: 7864434
[No Abstract] [Full Text] [Related]
20. Malignant hyperthermia.
Britt BA
Can Anaesth Soc J; 1985 Nov; 32(6):666-78. PubMed ID: 4075218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
